An open-label, Multinational, Phase IIIb Study to Evaluate Patient and Satisfaction, Safety and Efficacy of Subcutaneous Administration of Trastuzumab in Patients With HER2-Positive Early Breast Cancer (ML28851) in Adjuvant/Neo-Adjuvant Setting
| dc.contributor.author | Alsalef, K. | |
| dc.contributor.author | Ozguroglu, M. | |
| dc.contributor.author | Errihani, H. | |
| dc.contributor.author | Belbaraka, R. | |
| dc.contributor.author | Goktas, B. | |
| dc.contributor.author | Cicin, I. | |
| dc.contributor.author | Oukkal, M. | |
| dc.contributor.author | Mahfouf, H. | |
| dc.contributor.author | Mezlini, A. | |
| dc.contributor.author | Larbaoui, B. | |
| dc.contributor.author | Slim, B. A. | |
| dc.contributor.author | Uslu, R. | |
| dc.date.accessioned | 2021-03-05T12:11:38Z | |
| dc.date.available | 2021-03-05T12:11:38Z | |
| dc.identifier.citation | Cicin I., Oukkal M., Mahfouf H., Mezlini A., Larbaoui B., Slim B. A. , Uslu R., Errihani H., Alsalef K., Belbaraka R., et al., "An open-label, Multinational, Phase IIIb Study to Evaluate Patient and Satisfaction, Safety and Efficacy of Subcutaneous Administration of Trastuzumab in Patients With HER2-Positive Early Breast Cancer (ML28851) in Adjuvant/Neo-Adjuvant Setting", 11th European Breast Cancer Conference (EBCC), Barcelona, İspanya, 21 - 23 Mart 2018, cilt.92 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_abf54cb2-3d94-4aee-83ce-1324fc134546 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/114761 | |
| dc.identifier.uri | https://doi.org/10.1016/s0959-8049(18)30535-5 | |
| dc.language.iso | eng | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Onkoloji | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | ONKOLOJİ | |
| dc.title | An open-label, Multinational, Phase IIIb Study to Evaluate Patient and Satisfaction, Safety and Efficacy of Subcutaneous Administration of Trastuzumab in Patients With HER2-Positive Early Breast Cancer (ML28851) in Adjuvant/Neo-Adjuvant Setting | |
| dc.type | Bildiri | |
| dc.contributor.department | Trakya Üniversitesi , , | |
| dc.identifier.volume | 92 | |
| dc.contributor.firstauthorID | 153223 |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
-
Bildiri [64839]